MIST · Milestone Pharmaceuticals Inc. · Executive Compensation
Market Cap
$98.15M
Shares
124.50M
Volume · Oct 2
769.55K
Avg daily vol (3M)
1.42M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Joseph Oliveto | Chief Executive Officer & President | $2,121,015 |
| David Bharucha | Chief Medical Officer | $1,024,463 |
| Amit Hasija | Chief Financial Officer and Executive Vice President of Corporate Development | $991,905 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Joseph Oliveto | Chief Executive Officer | $882,261 |
| David Bharucha | Chief Medical Officer | $636,174 |
| Amit Hasija | Chief Financial Officer and Executive Vice President of Corporate Development | $601,517 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Joseph Oliveto | Chief Executive Officer | $1,978,092 |
| David Bharucha | Chief Medical Officer | $1,220,031 |
| Amit Hasija | Chief Financial Officer and Executive Vice President of Corporate Development | $1,006,337 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Joseph Oliveto | Chief Executive Officer | $2,965,827 |
| David Bharucha | Chief Medical Officer | $2,018,181 |
| Amit Hasija | Chief Financial Officer and Executive Vice President of Corporate Development | $1,324,579 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Joseph Oliveto | Chief Executive Officer | $4,099,905 |
| Amit Hasija | Chief Financial Officer and Executive Vice President of Corporate Development | $1,746,964 |
| Francis Plat | Chief Science Officer ^^ | $1,204,602 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Joseph Oliveto | Chief Executive Officer | $4,087,536 |
| Amit Hasija | Chief Financial Officer and Executive Vice President of | $1,992,732 |
| Francis Plat | Chief Science Officer ^^ | $1,810,191 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Amit Hasija | Chief Financial Officer and Executive Vice President of Corporate Development | $2,463,312 |
| Timothy Maness | Former Chief Accounting Officer | $1,111,453 |
| Joseph Oliveto | Chief Executive Officer | $784,988 |
| Francis Plat | Chief Medical Officer | $579,092 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Joseph Oliveto | Chief Executive Officer | $1,436,837 |
| Francis Plat | Chief Medical Officer | $636,609 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Robert J. Wills | director | Appointed | 2025-06-12 |
| Joseph C. Papa | director | Appointed | 2025-06-12 |
| Michael Tomsicek | director | Appointed | 2025-06-12 |
| Andrew R. Saik | director | Appointed | 2025-06-12 |
| Lisa M. Giles | director | Appointed | 2025-06-12 |
| Seth H.Z. Fischer | director | Appointed | 2025-06-12 |
| Stuart M. Duty | director | Appointed | 2025-06-12 |
| Joseph Oliveto | director | Appointed | 2025-06-12 |
| Joeseph C. Papa | member of the Board | Appointed | 2024-09-04 |
| Andrew Saik | Independent Director | Appointed | 2024-07-15 |
| Stuart Duty | Independent Director | Appointed | 2024-07-15 |
| Andrew R. Saik | director | Appointed | 2024-07-15 |
| Stuart M. Duty | director | Appointed | 2024-07-15 |
| Seth H.Z. Fischer | to the Board | Appointed | 2023-03-27 |
| Francis Plat | Chief Scientific Officer | Retired | 2022-12-06 |